Aravind Palraj/X
Sep 19, 2026, 01:24
Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points
Aravind Palraj, Senior Resident in Clinical Immunology and Rheumatology at Madras Medical College, shared a post on X:
“2025 EULAR Behçet’s syndrome update — 5 practical take-home points:
- Colchicine remains first-line for recurrent mucocutaneous disease and acute arthritis
- Behçet uveitis needs immunosuppression — glucocorticoids should not be used alone
- Pulmonary or peripheral arterial aneurysm – high-dose glucocorticoids with infliximab; embolisation is preferred over open surgery when intervention is needed
- Venous thrombosis – control inflammation first; anticoagulation is not automatic and pulmonary artery aneurysm must be excluded
- Major organ disease increasingly favors early intensive immunosuppression, often with monoclonal anti-TNF therapy
A useful update across mucocutaneous, ocular, vascular, neurologic and GI Behçet’s disease.”
Other posts featuring Aravind Palraj on Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation